Astellas Pharma Inc. - Other Cashflows From Financing Activities

Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Other-Cashflows-From-Financing-Activities" stands at 43.82 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the lowest value since 03/31/2023.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -79.92 percent compared to the value the year prior.
The 1 year change in percent is -79.92.
The 3 year change in percent is -45.31.
The 5 year change in percent is 61.73.
The 10 year change in percent is -86.22.

The Serie's long term average value is 178.87 Billion Japanese Yens. It's latest available value, on 06/30/2025, is 75.50 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2019, to it's latest available value, on 06/30/2025, is +1,060.46%.
The Serie's change in percent from it's maximum value, on 12/31/2017, to it's latest available value, on 06/30/2025, is -87.67%.